Nika Pharmaceuticals, Inc.
NIKA
$0.41
-$0.01-2.38%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 47.01% | -63.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 47.01% | -63.88% | |||
| Operating Income | -47.01% | 63.88% | |||
| Income Before Tax | -47.01% | 63.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -47.01% | 63.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -47.01% | 63.88% | |||
| EBIT | -47.01% | 63.88% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -- | -- | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | -- | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 0.30% | -2.12% | |||
| Average Diluted Shares Outstanding | 0.30% | -2.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||